Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIA-Plaque: Niacin + Statin for Plaque Stabilization in the Elderly
NCT00127218Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Sep 2003
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atherosclerosis and cardiovascular disease (CVD) comparing Statin + Niacin with Statin + Placebo (2 arms). Primary endpoint: Changes in Plaque Architecture and Composition Directly Measured by Magnetic Resonance Imaging (MRI) in the Aorta and Carotid Arteries at 18 months. Started Sep 2003; status: completed.
02
Drugs
niacin
03
Conditions
atherosclerosiscardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00127218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127218.